Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...

Michael Schumacher has reportedly made new progress in his recovery from the traumatic brain injury he suffered in a 2013 ...

Through her dance company and studio, Forward Space, where models and actresses come to sweat, Kristin Sudeikis has earned ...

Omega-3 fatty acids, creatine, magnesium and vitamin D support memory and brain function. Correcting low levels of these ...

A King County jury found Seattle was negligent in its response to the fatal shooting of a teenager in the Capitol Hill ...

Pharmaceutical companies are developing synthetic, bespoke versions of the drugs for therapeutic use, a line of research that ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...

Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in magic mushrooms, produces subtle but distinct effects on social behavior ...

Now neurostimulation treatment Exomind has come to Scotland. The cutting-edge, non-invasive brain stimulation technology was ...

A new study suggests that the long-term antidepressant effects of psychedelics may be driven by persistent changes in how ...

Researchers discovered that psilocybin produces subtle, context-dependent effects on social behavior and IL-6 mediated inflammation in female mice. Activity-based anorexia (ABA) mice exhibited ...